Megalencephalic leukoencephalopathy with subcortical cysts (MLC, MIM [\#604004](http://www.ncbi.nlm.nih.gov/omim/?term=604004)) is an autosomal recessive neurological disorder first described by van der Knaap *et al.*^[@bib1]^ that is characterized by early onset macrocephaly and delayed-onset neurological deterioration.^[@bib1]^ Patients with MLC show macrocephaly during the first year of life, followed by slowly progressive deterioration of motor functions with ataxia and spasticity. In such cases, brain magnetic resonance imaging (MRI) shows diffuse signal abnormality in the white matter of the cerebral hemisphere, and subcortical cysts are often observed in the anterior-temporal region and/or in the front-parietal area. The causative gene, *MLC1* (MIM [\#605908](http://www.ncbi.nlm.nih.gov/omim/?term=605908)), was first identified in 2001 and maps to chromosome band 22q13.33; this gene contains 12 exons.^[@bib2]^ *MLC1* mutations have been observed in 75% of patients with MLC.^[@bib3]^ Herein, we report the result of an ongoing study to obtain a genetic diagnosis for *MLC1*.

This study was approved by the Ethics Committee of Tokyo Women's Medical University. After obtaining written informed consent from patients or their families, blood samples were obtained from patients with a clinical diagnosis of MLC. The diagnosis was made based on previously defined criteria.^[@bib1],[@bib4]^ Genomic DNA was extracted from blood samples using the QIAamp DNA Extraction Kit (QIAGEN, Hamburg, Germany). Parental samples were also obtained to determine inheritance. All exons of *MLC1* were genotyped using standard Sanger sequencing.

We identified three types of *MLC1* mutations in seven unrelated Japanese patients with MLC ([Table 1](#tbl1){ref-type="table"}). Eleven alleles contained the c.278C\>T (p.S93L) missense mutation ([Supplementary Figure 1](#xob1){ref-type="supplementary-material"}) in exon 4 (78.6%), and all patients had p.S93L in either of the alleles ([Table 1](#tbl1){ref-type="table"}). Patients 1--4 showed homozygous patterns of p.S93L, and the remaining three patients were compound heterozygous for the mutation and one of other mutations. This mutation has been previously reported in individuals from Japan, Turkey and Finland.^[@bib2],[@bib5],[@bib6]^ Tsujino *et al.*^[@bib6]^ reported that p.S93L is a common mutation in Japanese patients with MLC, with 85.7% of patients and 71.4% alleles showing this mutation.^[@bib6]^ This finding was also confirmed in the present study. Although we did not analyze parental origins in patients 1--4 due to lack of parental samples, parental consanguinities in patients 1--3 and the high frequency of p.S93L suggest that these patients would be homozygous for p.S93L.

The second most common mutation, c.824C\>A (p.A275D) in exon 10 ([Supplementary Figure 1](#xob1){ref-type="supplementary-material"}), was observed in two alleles (14.3%) from patients 5 and 7 ([Table 1](#tbl1){ref-type="table"}). Compound heterozygosity was confirmed in these two patients because p.S93L and p.A275D were identified in either of the parents independently. Although this mutation was reported previously by Montagna *et al.*,^[@bib7]^ this is the first report in Japanese patients.

A single-nucleotide deletion, c.578delG (p.V194Sfs\*2) ([Supplementary Figure 1](#xob1){ref-type="supplementary-material"}), was identified in exon 7 in patient 6. To the best of our knowledge, this is a novel mutation. The mother of patient 6 was a carrier of p.S93L (heterozygous of p.S93L); however, the origin of c.578delG was unknown due to lack of a sample from his father. This deletion causes a frameshift mutation and creates a premature termination codon, leading to nonsense-mediated decay. As a consequence, this likely leads to a loss of function of *MLC1*. Such single-nucleotide deletions are rare in *MLC1*.

In the present study, all patients showed brain MRI abnormalities consistent with diffuse white matter abnormalities ([Figure 1](#fig1){ref-type="fig"}). Although most of the patients showed detectable subcortical cysts, particularly in anterior-temporal regions ([Figure 1](#fig1){ref-type="fig"}), some were too small to be detected in the regular images. The MLC patients could be classified into two groups according to age, that is, infant patients and patients older than the teenage years. Two infant patients were diagnosed with MLC as a result of examination for macrocephaly; no neurological findings were observed in either of these two patients at the time of genetic diagnosis.

In comparison, the older patients showed impaired motor and/or intellectual disability and required supports for daily life. Macrocephaly was observed in only two of the five older patients (2/5). The clinical courses and prognoses of these patients were variable. The onset of MLC in the four patients with the p.S93L homozygous mutation was variable, ranging from 15 months to 41 years. Patient 1, who was homozygous for p.S93L, was severely impaired and bedridden from the age of 4. On the other hand, patient 2 showed only mild cognitive and memory deficit and suffered seizures followed by weakness of the extremities at 47 years of age. This type of patient with a good long-term prognosis was also reported by Koyama *et al.*^[@bib8]^ Therefore, this may not necessarily indicate that p.S93L is the mutation causing severe neurological prognosis.

In MLC patients, provoked events are often observed after high fever and head trauma. We observed such provoked events in three patients ([Table 1](#tbl1){ref-type="table"}). Because the clinical severities of patients with MLC varied even among patients sharing identical genotypes, disease prognosis may be modified by environmental factors including fever, head trauma, unknown modifier genes, and epigenetic factors.
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![Brain magnetic resonance imaging findings. (**a** and **b**) Patient 1 examined at 55 years of age. The T1-weighted sagittal image (**a**) shows a subcortical cyst in the anterior-temporal region, and diffuse volume loss of the cerebrum is noted (**b**). (**c** and **d**) Patient 2 at 51 years of age. Although subcortical cysts are too small to be detected in the anterior-temporal regions (**c**), mild volume loss of the cerebrum is detectable (**d**). (**e** and **f**) Patient 3 at 16 years of age. (**g** and **h**) and patient 4 at 30 years of age. The T1-weighted axial image (**g**) shows subcortical cysts in the anterior-temporal regions. (**i** and **j**) Patient 5 at 18 years of age. An asymmetric subcortical cyst in the right anterior-temporal regions is noted in the T1-weighted axial image (**i**). (**k** and **l**) Patient 6 at 11 months of age. (**m** and **n**) patient 7 at 9 months of age. The T2-weighted axial images indicate high intensity in the white matter in all patients (**b**--**f**, **h** and **j**--**n**). Subcortical cysts in the anterior-temporal regions are detectable in some of the T2-weighted axial images (**e** and **m**).](hgv201419-f1){#fig1}

###### Summaries of the clinical information of the patients and the results of mutation analyses

  *Patient*    *Gender*   *Present age (y/m)*   *Onset age (y/m)*     *First symptom*               *Present status*            *Consanguinity*     *Mutations*     *Parental origins*    *Provoking event*    *Macrocephaly/OFC* [a](#t1-fn1){ref-type="fn"} *(measured age)*   *Seizures (onset age) (y/m)*
  ----------- ---------- --------------------- ------------------- ---------------------- ------------------------------------ ----------------- ----------------- -------------------- --------------------- ----------------------------------------------------------------- ------------------------------
  1               F              55 y               1 y 10 m              Seizure                      Bedridden                      \+             S93L/S93L        Not confirmed      Head trauma at 18 m                          \+ 58.5 cm (55 y)                                   \+ (22 m)
  2               F              51 y                 41 y          Cognitive impairment   Intellectual disability Spasticity         \+             S93L/S93L        Not confirmed               −                                    − 58 cm (51 y)                                     \+ (47 y)
  3               F              36 y                1 y 6 m            Macrocephaly                   Bedridden                      \+             S93L/S93L        Not confirmed      Head trauma at 2 y                      \+ 54 cm (1 y) 62 cm (15 y)                               \+ (2 y)
  4               F              31 y                1 y 3 m              Seizure               Intellectual disability                −             S93L/S93L        Not confirmed         Fever at 15 m                                   \+ NI                                           \+ NI
  5               F              18 y                  2y             Motor disability             Inability to walk                   −            S93L/A275D          Confirmed                 −                                    − 58 cm (18 y)                                         −
  6               M              11 m                 11 m              Macrocephaly                       NA                          −          S93L/V194Sfs\*2     Not confirmed               −                             \+ 50.3 cm (11 m; +2.9 s.d.)                                  −
  7               F               9 m                  9 m              Macrocephaly                       NA                          −            S93L/A275D          Confirmed                 −                              \+ 49.5 cm (9 m; +2.5 s.d.)                                  −

Abbreviations: F, female; M, male; m, months; NI, no detailed information; s.d., standard deviation; y, years.

Mean OFC for adult Japanese females is 54.6 cm (the third percentile=52.0 cm, the 97th percentile=58.1 cm).
